Scripx® Compounding Pharmacy: Detailed Company Information & Corporate Profile

Contact top employees from Scripx® Compounding Pharmacy

Summary

The company currently specializes in the Retail area. The annual revenue of Scripx® Compounding Pharmacy varies between 1 and 10M. To connect with Scripx® Compounding Pharmacy employee register on SignalHire.

Scripx® Compounding Pharmacy Websitescripx.com
Phone Number(469) 596-0341
Industries
Scripx® Compounding Pharmacy Headquarters address5706 E Mockingbird Ln, Dallas, Texas, 75206 US
Company Size10-50 employees
Specialtiescompounding, pharmacy, telemedicine, digital health, specialty pharmacy, prep, mental health, hiv, diabetes, Mark Cuban Cost Plus Drugs, Ingrezza, Ozempic, Wegovy, GLP-1, Low Dose Naltrexone, HRT
Founded2018
Estimated Annual Revenue$1 - 10M

Workforce Turnover

Corporate Tenure Analytics

arrow

Scripx® Compounding Pharmacy's workforce includes employees across a wide range of tenure levels.

67% have been with the company for 3 to 4 years33% have been with the company for 5 to 7 years
Contact top employees from Scripx® Compounding Pharmacy

Scripx® Compounding Pharmacy Corporate Information: FAQ

Scripx® Compounding Pharmacy operates in the Retailing industries. More details can be found on the official website: scripx.com.
The headquarters of Scripx® Compounding Pharmacy are located in Dallas, United States.
You can contact Scripx® Compounding Pharmacy by phone at (469) 596-0341.
Scripx® Compounding Pharmacy currently employs 10-50 people.
Scripx® Compounding Pharmacy's revenue is approximately 879.7K.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP